Keywords: -leukosite, ilex, meet, fda, over, campath, leukosite

-LeukoSite and ILEX meet with FDA over Campath

Article | 08 April 1999

- LeukoSite and ILEX Oncology have met with the US Food and DrugAdministration for a pre-Biologics Licence Application meeting regarding their ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Alemtuzumab

Campath

Go to drug listing